{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:07:32Z","timestamp":1775246852510,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.carrev.2025.04.020","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:03:54Z","timestamp":1744729434000},"page":"74-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Outcomes of patients with cancer with acute coronary syndrome-associated cardiogenic shock"],"prefix":"10.1016","volume":"80","author":[{"given":"Orly","family":"Leiva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Pauwaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason N.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Alvarez-Cardona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Alviar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric H.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.carrev.2025.04.020_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000590","article-title":"Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States","volume":"3","author":"Kolte","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.carrev.2025.04.020_bb0010","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7326\/0003-4819-149-9-200811040-00005","article-title":"Ten-year trends in the incidence and treatment of cardiogenic shock","volume":"149","author":"Jeger","year":"2008","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.carrev.2025.04.020_bb0015","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaccao.2021.08.011","article-title":"Common pathophysiology in Cancer, atrial fibrillation, atherosclerosis, and thrombosis: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Leiva","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"23","key":"10.1016\/j.carrev.2025.04.020_bb0020","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/eurheartj\/ehz851","article-title":"Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA","volume":"41","author":"Bharadwaj","year":"2020","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.carrev.2025.04.020_bb0025","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/eurheartj\/ehy769","article-title":"Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States","volume":"40","author":"Potts","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.carrev.2025.04.020_bb0030","article-title":"Impact of active and historical cancers on the management and outcomes of acute myocardial infarction complicating cardiogenic shock","volume":"49","author":"Patlolla","year":"2022","journal-title":"Tex Heart Inst J"},{"issue":"7","key":"10.1016\/j.carrev.2025.04.020_bb0035","first-page":"639","article-title":"Treatment of patients with myocardial infarction depends on history of cancer","volume":"7","author":"Rohrmann","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"6","key":"10.1016\/j.carrev.2025.04.020_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.009236","article-title":"Impact of a prior cancer diagnosis on quality of care and survival following acute myocardial infarction: retrospective population-based cohort study in England","volume":"16","author":"Teece","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"10.1016\/j.carrev.2025.04.020_bb0045","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ehjqcco\/qcad012","article-title":"Outcomes of ST elevation myocardial infarction in patients with cancer; a nationwide study","volume":"9","author":"Dafaalla","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"22","key":"10.1016\/j.carrev.2025.04.020_bb0050","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehz013","article-title":"Management of acute coronary syndromes in patients with cancer: room for improvement","volume":"40","author":"Nohria","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.carrev.2025.04.020_bb0055","first-page":"279","article-title":"Preferences and attitudes of cardiologists in management of patients with cancer","volume":"3","author":"Azar","year":"2022","journal-title":"Palliat Med Rep"},{"issue":"10","key":"10.1016\/j.carrev.2025.04.020_bb0060","first-page":"682","article-title":"Characteristics, management, and outcomes of active cancer patients with cardiogenic shock","volume":"12","author":"Merdji","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.carrev.2025.04.020_bb0065","unstructured":"Leiva O, Cheng RK, Pauwaa S, Katz JN, Alvarez-Cardona J, Bernard S, et al. Outcomes of patients with Cancer with myocardial infarction-associated cardiogenic shock managed with mechanical circulatory support. J Soc Cardiovasc Angiogr Intervent."},{"issue":"9","key":"10.1016\/j.carrev.2025.04.020_bb0070","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.carrev.2025.04.020_bb0075","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2025.04.020_bb0080","series-title":"Healthcare Cost and Utilization Project (HCUP)","author":"HCUP Nationwide Readmissions Database (NRD)","year":"2014"},{"issue":"2","key":"10.1016\/j.carrev.2025.04.020_bb0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canep.2011.05.016","article-title":"Recent decline in the U.S. death rate from myeloproliferative neoplasms, 1999-2006","volume":"36","author":"Polednak","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.carrev.2025.04.020_bb0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.thromres.2020.06.017","article-title":"Patient outcomes in myeloproliferative neoplasm-related thrombosis: insights from the National Inpatient Sample","volume":"194","author":"Ulanja","year":"2020","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.carrev.2025.04.020_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"10132","key":"10.1016\/j.carrev.2025.04.020_bb0100","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.carrev.2025.04.020_bb0105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.amjmed.2022.12.033","article-title":"Frailty assessment and perioperative major adverse cardiovascular events after noncardiac surgery","volume":"136","author":"Siddiqui","year":"2023","journal-title":"Am J Med"},{"key":"10.1016\/j.carrev.2025.04.020_bb0110","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.carrev.2025.04.020_bb0115","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","article-title":"Impella support for acute myocardial infarction complicated by cardiogenic shock","volume":"139","author":"Schrage","year":"2019","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.carrev.2025.04.020_bb0120","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.2020.0254","article-title":"Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock","volume":"323","author":"Dhruva","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2025.04.020_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2020.08.012","article-title":"Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction-related cardiogenic shock from 2005 to 2017: a nationwide cohort study","volume":"229","author":"Lauridsen","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2025.04.020_bb0130","article-title":"Trends and outcomes of different mechanical circulatory support modalities for acute myocardial infarction associated cardiogenic shock in patients undergoing early revascularization","volume":"46","author":"Ali","year":"2024","journal-title":"Am Heart J Plus"},{"issue":"15","key":"10.1016\/j.carrev.2025.04.020_bb0135","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-19-00226","article-title":"Ten-year trends, predictors and outcomes of mechanical circulatory support in percutaneous coronary intervention for acute myocardial infarction with cardiogenic shock","volume":"16","author":"Vallabhajosyula","year":"2021","journal-title":"EuroIntervention"},{"issue":"8","key":"10.1016\/j.carrev.2025.04.020_bb0140","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.carrev.2018.10.005","article-title":"Outcomes for cancer patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"20","author":"Jacobs","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"issue":"8","key":"10.1016\/j.carrev.2025.04.020_bb0145","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s11864-023-01110-2","article-title":"Interventional cardio-oncology: unique challenges and considerations in a high-risk population","volume":"24","author":"Leiva","year":"2023","journal-title":"Curr Treat Options in Oncol"},{"issue":"6","key":"10.1016\/j.carrev.2025.04.020_bb0150","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1253\/circj.CJ-20-1119","article-title":"Clinical outcomes after percutaneous coronary intervention in patients with Cancer","volume":"85","author":"Kanenawa","year":"2021","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.carrev.2025.04.020_bb0155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1536\/ihj.20-452","article-title":"The effect of a Cancer history on patients with acute myocardial infarction after percutaneous coronary intervention","volume":"62","author":"Takeuchi","year":"2021","journal-title":"Int Heart J"},{"key":"10.1016\/j.carrev.2025.04.020_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132165","article-title":"In-hospital and readmission outcomes of patients with cancer admitted for pulmonary embolism treated with or without catheter-based therapy","volume":"408","author":"Leiva","year":"2024","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2025.04.020_bb0165","first-page":"348","article-title":"Catheter-based therapy for intermediate or high-risk pulmonary embolism is associated with lower in-hospital mortality in patients with cancer: insights from the National Inpatient Sample","volume":"103","author":"Leiva","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.carrev.2025.04.020_bb0170","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"Moller","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.carrev.2025.04.020_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020627","article-title":"Sensitivity and specificity of breast cancer ICD-9-CM codes in three Italian administrative healthcare databases: a diagnostic accuracy study","volume":"8","author":"Abraha","year":"2018","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.carrev.2025.04.020_bb0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00008469-200506000-00002","article-title":"The data quality of haematological malignancy ICD-10 diagnoses in a population-based hospital discharge registry","volume":"14","author":"Norgaard","year":"2005","journal-title":"Eur J Cancer Prev"},{"issue":"7","key":"10.1016\/j.carrev.2025.04.020_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055459","article-title":"Accuracy of algorithms to identify patients with a diagnosis of major cancers and cancer-related adverse events in an administrative database: a validation study in an acute care hospital in Japan","volume":"12","author":"Fujiwara","year":"2022","journal-title":"BMJ Open"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892500171X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892500171X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:02:03Z","timestamp":1762570923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155383892500171X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":37,"alternative-id":["S155383892500171X"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.04.020","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of patients with cancer with acute coronary syndrome-associated cardiogenic shock","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}